Literature DB >> 2514798

Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein.

M Noda1, S C Tsai, R Adamik, D A Bobak, J Moss, M Vaughan.   

Abstract

Cholera toxin catalyzes the ADP-ribosylation that results in activation of the stimulatory guanine nucleotide-binding protein of the adenylyl cyclase system, known as Gs. The toxin also ADP-ribosylates other proteins and simple guanidino compounds and auto-ADP-ribosylates its AI protein (CTA1). All of the ADP-ribosyltransferase activities of CTAI are enhanced by 19-21-kDa guanine nucleotide-binding proteins known as ADP-ribosylation factors, or ARFs. CTAI contains a single cysteine located near the carboxy terminus. CTAI was immobilized through this cysteine by reaction with iodoacetyl-N-biotinyl-hexylenediamine and binding of the resulting biotinylated protein to avidin-agarose. Immobilized CTAI catalyzed the ARF-stimulated ADP-ribosylation of agmatine. The reaction was enhanced by detergents and phospholipid, but the fold stimulation by purified sARF-II from bovine brain was considerably less than that observed with free CTA. ADP-ribosylation of Gsa by immobilized CTAI, which was somewhat enhanced by sARF-II, was much less than predicted on the basis of the NAD:agmatine ADP-ribosyltransferase activity. Immobilized CTAI catalyzed its own auto-ADP-ribosylation as well as the ADP-ribosylation of the immobilized avidin and CTA2, with relatively little stimulation by sARF-II. ADP-ribosylation of CTA2 by free CTAI is minimal. These observations are consistent with the conclusion that the cysteine near the carboxy terminus of the toxin is not critical for ADP-ribosyltransferase activity or for its regulation by sARF-II. Biotinylation and immobilization of the toxin through this cysteine may, however, limit accessibility to Gsa or SARF-II, or perhaps otherwise reduce interaction with these proteins whether as substrates or activator.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514798     DOI: 10.1021/bi00445a057

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Identification in traditional herbal medications and confirmation by synthesis of factors that inhibit cholera toxin-induced fluid accumulation.

Authors:  Hiroshi Oi; Daisuke Matsuura; Masami Miyake; Masamiti Ueno; Izumi Takai; Takeshi Yamamoto; Masayoshi Kubo; Joel Moss; Masatoshi Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 2.  Regulating the large Sec7 ARF guanine nucleotide exchange factors: the when, where and how of activation.

Authors:  John Wright; Richard A Kahn; Elizabeth Sztul
Journal:  Cell Mol Life Sci       Date:  2014-04-13       Impact factor: 9.261

3.  A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.

Authors:  S Yamamoto; H Kiyono; M Yamamoto; K Imaoka; K Fujihashi; F W Van Ginkel; M Noda; Y Takeda; J R McGhee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity.

Authors:  S Yamamoto; Y Takeda; M Yamamoto; H Kurazono; K Imaoka; M Yamamoto; K Fujihashi; M Noda; H Kiyono; J R McGhee
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.